Business Description
Athenex Inc
NAICS : 325412
SIC : 2834
ISIN : US04685N2027
Compare
Compare
Traded in other countries / regions
2MT0.Germany IPO Date
2019-03-06Description
Athenex Inc is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. Its current clinical pipeline is derived from Orascovery, based on a P-glycoprotein (P-gp) pump inhibitor, Src Kinase inhibition, T-cell receptor-engineered T-cells, and arginine deprivation therapy technology platforms. It is primarily engaged in conducting research and development activities through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting preclinical and clinical testing, recruiting personnel, identifying and evaluating additional drug candidates for potential in-licensing or acquisition, and raising capital to support development and commercialization activities.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | 10.51 | |||||
| 12-1 Month Momentum % | -60.81 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -73.95 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-Forward-Revenue | 1.46 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Athenex Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 98.818 | ||
| EPS (TTM) (€) | -15.072 | ||
| Beta | 0 | ||
| Volatility % | 113.7 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0.018643 | ||
| 20-Day SMA (€) | 0 | ||
| 12-1 Month Momentum % | -60.81 | ||
| 52-Week Range (€) | 0.149 - 22.08 | ||
| Shares Outstanding (Mil) | 8.7 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Athenex Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Athenex Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Athenex Inc Frequently Asked Questions
What is Athenex Inc(STU:2MT0)'s stock price today?
The current price of STU:2MT0 is €0.18. The 52 week high of STU:2MT0 is €22.08 and 52 week low is €0.15.
When is next earnings date of Athenex Inc(STU:2MT0)?
The next earnings date of Athenex Inc(STU:2MT0) is 2024-11-29 Est..
Does Athenex Inc(STU:2MT0) pay dividends? If so, how much?
Athenex Inc(STU:2MT0) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers